Pro Share Advisors LLC Insmed Inc Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Insmed Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 39,850 shares of INSM stock, worth $2.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
39,850
Previous 30,140 32.22%
Holding current value
$2.79 Million
Previous $2.02 Million 44.08%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$62.0 - $79.01 $602,020 - $767,187
9,710 Added 32.22%
39,850 $2.91 Million
Q2 2024

Aug 13, 2024
SELL
$22.0 - $69.71 $112,222 - $355,590
-5,101 Reduced 14.47%
30,140 $2.02 Million
Q1 2024

May 08, 2024
BUY
$25.72 - $29.94 $82,766 - $96,346
3,218 Added 10.05%
35,241 $956,000
Q4 2023

Feb 14, 2024
BUY
$23.42 - $31.74 $128,763 - $174,506
5,498 Added 20.73%
32,023 $992,000
Q3 2023

Nov 13, 2023
BUY
$19.86 - $26.93 $10,962 - $14,865
552 Added 2.13%
26,525 $669,000
Q2 2023

Aug 10, 2023
BUY
$16.44 - $21.1 $9,962 - $12,786
606 Added 2.39%
25,973 $548,000
Q1 2023

May 11, 2023
SELL
$16.26 - $21.73 $52,552 - $70,231
-3,232 Reduced 11.3%
25,367 $432,000
Q4 2022

Feb 02, 2023
BUY
$16.98 - $23.15 $91,012 - $124,083
5,360 Added 23.06%
28,599 $571,000
Q3 2022

Nov 04, 2022
BUY
$20.88 - $28.21 $11,149 - $15,064
534 Added 2.35%
23,239 $500,000
Q2 2022

Aug 01, 2022
SELL
$17.07 - $25.71 $200,538 - $302,041
-11,748 Reduced 34.1%
22,705 $448,000
Q1 2022

May 10, 2022
SELL
$20.42 - $28.13 $163,666 - $225,461
-8,015 Reduced 18.87%
34,453 $809,000
Q4 2021

Feb 08, 2022
BUY
$25.89 - $33.45 $80,621 - $104,163
3,114 Added 7.91%
42,468 $1.16 Million
Q3 2021

Nov 12, 2021
SELL
$22.46 - $29.47 $181,813 - $238,559
-8,095 Reduced 17.06%
39,354 $1.08 Million
Q2 2021

Aug 13, 2021
BUY
$24.17 - $36.01 $148,452 - $221,173
6,142 Added 14.87%
47,449 $1.35 Million
Q1 2021

May 14, 2021
BUY
$32.28 - $44.3 $101,972 - $139,943
3,159 Added 8.28%
41,307 $1.41 Million
Q4 2020

Feb 09, 2021
BUY
$31.45 - $40.54 $295,189 - $380,508
9,386 Added 32.63%
38,148 $1.27 Million
Q3 2020

Nov 13, 2020
SELL
$26.0 - $34.5 $29,718 - $39,433
-1,143 Reduced 3.82%
28,762 $924,000
Q2 2020

Aug 03, 2020
BUY
$14.11 - $29.42 $174,978 - $364,837
12,401 Added 70.85%
29,905 $824,000
Q1 2020

May 15, 2020
SELL
$13.63 - $33.98 $189,170 - $471,608
-13,879 Reduced 44.22%
17,504 $281,000
Q4 2019

Feb 12, 2020
SELL
$16.12 - $24.98 $46,860 - $72,616
-2,907 Reduced 8.48%
31,383 $749,000
Q3 2019

Nov 12, 2019
BUY
$15.49 - $25.78 $9,851 - $16,396
636 Added 1.89%
34,290 $605,000
Q2 2019

Aug 13, 2019
SELL
$23.0 - $32.19 $23,299 - $32,608
-1,013 Reduced 2.92%
33,654 $862,000
Q1 2019

May 15, 2019
BUY
$13.91 - $31.15 $7,149 - $16,011
514 Added 1.5%
34,667 $1.01 Million
Q4 2018

Feb 14, 2019
SELL
$11.6 - $18.7 $76,931 - $124,018
-6,632 Reduced 16.26%
34,153 $448,000
Q3 2018

Nov 14, 2018
SELL
$18.95 - $28.08 $28,500 - $42,232
-1,504 Reduced 3.56%
40,785 $825,000
Q2 2018

Aug 13, 2018
SELL
$20.0 - $29.72 $58,360 - $86,722
-2,918 Reduced 6.45%
42,289 $1 Million
Q1 2018

May 14, 2018
SELL
$21.69 - $32.99 $160,787 - $244,554
-7,413 Reduced 14.09%
45,207 $1.02 Million
Q4 2017

Feb 14, 2018
BUY
$26.43 - $31.78 $327,229 - $393,468
12,381 Added 30.77%
52,620 $1.64 Million
Q3 2017

Nov 13, 2017
BUY
$11.61 - $31.21 $33,053 - $88,854
2,847 Added 7.61%
40,239 $1.26 Million
Q2 2017

Aug 11, 2017
BUY
N/A
37,392
37,392 $642,000

Others Institutions Holding INSM

# of Institutions
467
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.48B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email